Guidance In The Works For Unmet Need In Serious Bacterial Infections

CHICAGO – FDA hopes to have a draft guidance for industry on developing antibiotics for serious bacterial infection with unmet medical need ready for public review in the first quarter of 2012, Edward Cox, director of FDA’s Office of Antimicrobial Products, told an audience at the Interscience Conference on Antimicrobial Agents and Chemotherapy in Chicago.